The market for medical technology and products is characterized by sustainable growth. The innovation cycles are short. However, approval procedures differ widely from country to country and are overall very complex. Restrictions due to trade policies and exchange rate fluctuations are further challenges that providers have to face. That is why they require competent and flexible partners by their side to give them significant additional support. Regardless whether in product development, manufacturing individual components, complete end products or sales and after-sales services: suppliers in the medical technology industry meet these high requirements. This year, they will once again impressively demonstrate these abilities at their leading international information and communication platform - COMPAMED 2018, which will take place from November 12 - 15 in Düsseldorf, Germany.

Again, we can expect a future-oriented exchange with an eye to innovative solutions to ensure better healthcare among the over 800 COMPAMED exhibitors and their customers, who are made up of, for example, the over 5,000 exhibitors at MEDICA, the world’s largest medical trade fair that takes place concurrently with COMPAMED. Exciting trends are currently setting the pace. For quite some time now, ‘dematerialization‘ and ‘digitalization’ or ‘networking’ have been buzzwords that quite fittingly describe the events around medical technological product development and are still very much current.

Providers are turning to suppliers to seek ever more delicate, lighter and at the same time more advanced components such as sensors, chips, wireless modules and even accompanying energy savers or information savers.

These then can be installed in wearables used for diagnostics of vital signs. These devices are in high demand. Another large application is the field of active implants. Participants in this year’s COMPAMED Spring Convention have already learned why these are among the most technically sophisticated medical products with particularly high research, development, production and approval requirements and which are currently the most interesting innovations in this area.

Miniaturized components are among these innovations as well as developments in coating technologies. Experts, for example, describe parylene coatings as multi-talents. Due to their organic compatibility and other characteristics, these progressive, plastic-based coatings are particularly well suited for encapsulated casings for implants. In addition, they can be made into ultra-thin products, which is why they are used in stent technologies, neurostimulation or infusion technologies.

Association Viewpoints Homepage